Karus Therapeutics Limited
3 clinical trials · Sponsor
◉ Watch Karus Therapeutics Limited
| Record | Firm | Date |
|---|---|---|
| A Study of Selective HDAC6 Inhibition With KA2507 in Advanced Biliary Tract Cancer (NCT04186156) | Karus Therapeutics Limited | 2020-03-05 |
Track Karus Therapeutics Limited automatically
Every clearance here is in the API, with alerts when new ones post.